Skip to Main Content

Author Details

Karel Pacak
Eunice Kennedy Shriver National Institute of Child Health and Human Development
1986
655
90
PMIDPaper TitleJournal TitlePublished Year
37647861Asymmetric Adrenals: Sexual Dimorphism of Adrenal Tumors.J Clin Endocrinol Metab2024
36190922Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma.J Clin Endocrinol Metab2023
37902037Regulation of epinephrine biosynthesis in HRAS-mutant paragangliomas.Endocr Relat Cancer2023
37515400Paediatric phaeochromocytoma and paraganglioma: A clinical update.Clin Endocrinol (Oxf)2023
37156926Molecular imaging phenotyping of germline fumarate hydratase (FH) pathogenic variant-positive metastatic pheochromocytoma.Eur J Nucl Med Mol Imaging2023
37453673A novel HIF2A mutation causes dyslipidemia and promotes hepatic lipid accumulation.Pharmacol Res2023
37185155Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma.Endocr Relat Cancer2023
36946182Metastatic Pheochromocytoma and Paraganglioma: Somatostatin Receptor 2 Expression, Genetics, and Therapeutic Responses.J Clin Endocrinol Metab2023
37450881Pacak-Zhuang syndrome: a model providing new insights into tumor syndromes.Endocr Relat Cancer2023
37342263Editorial: Pediatric adrenal neoplasms.Front Endocrinol (Lausanne)2023
37342258Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy.Front Endocrinol (Lausanne)2023
37011647Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants.Lancet Diabetes Endocrinol2023
37011227Immune Landscape of Pheochromocytoma and Paraganglioma: A Potentially Novel Avenue for Prognostic Reclassification?J Clin Endocrinol Metab2023
37339049A protocol for visualization of murine in situ neurovascular interfaces.STAR Protoc2023
37434263rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses.J Exp Clin Cancer Res2023
37474439Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort.Lancet Digit Health2023
37030115The combination of immunotherapy and a glutamine metabolism inhibitor represents an effective therapeutic strategy for advanced and metastatic murine pancreatic adenocarcinoma.Int Immunopharmacol2023
36883571International symposium on pheochromocytoma: an event of dedicated healthcare professionals and researchers striving for better patient outcomes.Endocr Relat Cancer2023
36624099Author Correction: Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.Nat Commun2023
36854674Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.Nat Commun2023
36538160Reduced coronary artery luminal area in pheochromocytoma and paraganglioma patients.J Endocrinol Invest2023
36733351Clinical utility of nuclear imaging in the evaluation of pediatric adrenal neoplasms.Front Oncol2023
36633962Nuclear medicine in pheochromocytoma and paraganglioma: at a crossroads with precision medicine.Endocr Relat Cancer2023
36759198The Emergence of Somatostatin Antagonist-Based Theranostics: Paving the Road Toward Another Success?J Nucl Med2023
36370152Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis.Endocrine2023
36302175A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma.Clin Cancer Res2023
34147030Personalized Management of Pheochromocytoma and Paraganglioma.Endocr Rev2022
35536703Functional Imaging of Neuroendocrine Tumors: Stacking the Odds in a Patient's Favor.J Clin Endocrinol Metab2022
35500459Determinants of disease-specific survival in patients with and without metastatic pheochromocytoma and paraganglioma.Eur J Cancer2022
35489703Somatic Mosaicism of EPAS1 Mutations in Pacak-Zhuang Syndrome.Endocr Pract2022
35861986Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis.Eur J Endocrinol2022
35621181Supportive management of patients with pheochromocytoma/paraganglioma undergoing noninvasive treatment.Curr Opin Endocrinol Diabetes Obes2022
35618479Choice Is Good at Times: The Emergence of [<sup>64</sup>Cu]Cu-DOTATATE-Based Somatostatin Receptor Imaging in the Era of [<sup>68</sup>Ga]Ga-DOTATATE.J Nucl Med2022
36515265A remarkable adaptive paradigm of heart performance and protection emerges in response to marked cardiac-specific overexpression of ADCY8.Elife2022
36439433PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma.Front Oncol2022
36428741Preclinical Models of Neuroendocrine Neoplasia.Cancers (Basel)2022
36150627New Biology of Pheochromocytoma and Paraganglioma.Endocr Pract2022
36310832<sup>68</sup>Ga-DOTATATE Avid Metastatic Vertebral Renal Cell Carcinoma in the Setting of von Hippel-Lindau Syndrome.Nucl Med Mol Imaging2022
35903274Pediatric Metastatic Pheochromocytoma and Paraganglioma: Clinical Presentation and Diagnosis, Genetics, and Therapeutic Approaches.Front Endocrinol (Lausanne)2022
36271074Single-nuclei and bulk-tissue gene-expression analysis of pheochromocytoma and paraganglioma links disease subtypes with tumor microenvironment.Nat Commun2022
36232321Chronic Ethanol Consumption Alters Presynaptic Regulation of Dorsal Striatal Dopamine Release in C57BL/6J Mice.Int J Mol Sci2022
36353857A 13-Year-Old Male With Left Eye Swelling.Pediatrics2022
36093861Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia.J Bone Miner Res2022
36010880Performances of Functional and Anatomic Imaging Modalities in <i>Succinate Dehydrogenase A-</i>Related Metastatic Pheochromocytoma and Paraganglioma.Cancers (Basel)2022
35977518Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer.Cell Rep2022
35973976Targeted Therapies in Pheochromocytoma and Paraganglioma.J Clin Endocrinol Metab2022
35158861New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications.Cancers (Basel)2022
35171114Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine.Endocr Relat Cancer2022
35324454Personalized drug testing in human pheochromocytoma/paraganglioma primary cultures.Endocr Relat Cancer2022
34792634Correction to: Differences in clinical presentation and management between pre- and postsurgical diagnoses of urinary bladder paraganglioma: is there clinical relevance? A systematic review.World J Urol2022
  • 1 - 50 of 655

Recommended Authors

Hamadan University of Medical Sciences
Career Start Year 2010
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 2
Stanford University
Career Start Year 2005
Number of shared co-authors 0
The Ohio State University Wexner Medical Center
Career Start Year 2004
Number of shared co-authors 0
Massachusetts General Hospital/Harvard Medical School
Career Start Year 2004
Number of shared co-authors 5
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Career Start Year 2000
Number of shared co-authors 3
Dana-Farber Cancer Institute
Career Start Year 1999
Number of shared co-authors 5
Nepean Hospital
Career Start Year 1999
Number of shared co-authors 0
Johns Hopkins University
Career Start Year 1998
Number of shared co-authors 3
The Ottawa Hospital/University of Ottawa
Career Start Year 1994
Number of shared co-authors 0
Olivia Newton-John Cancer Research Institute
Career Start Year 1994
Number of shared co-authors 0
McMaster University
Career Start Year 1991
Number of shared co-authors 0
Wellcome-MRC Institute of Metabolic Science and Addenbrooke's Hospital
Career Start Year 1990
Number of shared co-authors 0
Akron Children's Hospital
Career Start Year 1988
Number of shared co-authors 2
Erasmus MC Cancer Institute, University Medical Center Rotterdam
Career Start Year 1988
Number of shared co-authors 1
university of california los angeles
Career Start Year 1987
Number of shared co-authors 4
Lineberger Comprehensive Cancer Center, University of North Carolina
Career Start Year 1987
Number of shared co-authors 2
University of California san francisco
Career Start Year 1986
Number of shared co-authors 1
The University of Texas M.D. Anderson Cancer Center
Career Start Year 1981
Number of shared co-authors 6
Groupe Hospitalier Universitaire Pitie-Salpetriere
Career Start Year 1981
Number of shared co-authors 2
Inova Health System
Career Start Year 1979
Number of shared co-authors 2
MD Anderson Cancer Center
Career Start Year 1978
Number of shared co-authors 4
Institute for Genomic Medicine, University of California San Diego
Career Start Year 1978
Number of shared co-authors 2
University of Texas Southwestern Medical Center
Career Start Year 1977
Number of shared co-authors 0
Groupement Hospitalier EST, Universite de Lyon
Career Start Year 1976
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 3
INSERM U8, CNRS UMR5292, Universite de Lyon
Career Start Year 1974
Number of shared co-authors 0
University of Virginia School of Medicine
Career Start Year 1966
Number of shared co-authors 3
Massachusetts General Hospital, Harvard Medical School
Career Start Year 1965
Number of shared co-authors 1
Massachusetts General Hospital
Career Start Year 1960
Number of shared co-authors 1

Collaborators

National Cancer Institute, National Institutes of Health
Co-authored papers 62
Stanford University School of Medicine
Co-authored papers 38
Co-authored papers 32
Center for Cancer Research
Co-authored papers 30
Co-authored papers 26
National Cancer Institute, National Institutes of Health
Co-authored papers 20
National Human Genome Research Institute
Co-authored papers 15
Co-authored papers 15
National Cancer Institute, National Institutes of Health
Co-authored papers 14
Indiana University School of Medicine
Co-authored papers 14
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 12
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 11
National Cancer Institute
Co-authored papers 10
National Cancer Institute, National Institutes of Health
Co-authored papers 8
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers 8
Co-authored papers 8
Radboud University Medical Centre
Co-authored papers 7
National Eye Institute, National Institutes of Health
Co-authored papers 7
St Jude Children's Research Hospital
Co-authored papers 6
Co-authored papers 5
Osteosarcoma Institute
Co-authored papers 5
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
National Institutes of Digestive Disease and Kidney, National Institutes of Health
Co-authored papers 5
and Blood Institute, National Institutes of Health
Co-authored papers 5
From Foundation Medicine
Co-authored papers 4
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 4
Co-authored papers 4
University of California los angeles
Co-authored papers 4
Clinical Center, National Institutes of Health
Co-authored papers 3
National Institute of Biomedical Imaging and Bioengineering
Co-authored papers 3